Reuters logo
BRIEF-Merz, Teijin announce partnership to bring Xeomin to Japan
October 12, 2017 / 11:26 AM / 2 months ago

BRIEF-Merz, Teijin announce partnership to bring Xeomin to Japan

Oct 12 (Reuters) - Teijin Ltd:

* Merz and Teijin announce partnership to bring Xeomin (Incobotulinumtoxina) to Japan

* Entered into strategic license and co-development agreement with merz for commercialization of xeomin (incobotulinumtoxina) for Japan​

* Merz sponsors 2 clinical trials in Japan covering spasticity of upper, lower limbs; upper limb trial completion seen in 2018​​

* ‍Under terms of agreement, Merz will receive an upfront payment in addition to milestones and royalties​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below